Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

11 results about "Surgical removal" patented technology

Surgical removal. During surgical removal, the skin is numbed with an injection of a local anesthetic. The tattoo is removed with a scalpel, and the edges of skin are stitched back together. After the procedure, antibacterial ointment helps promote healing.

Self-breaking outer drainage tube

PendingCN121868601AIntravenous devicesSuction devicesPancreatic juiceIntestinal walls
The invention discloses a self-breaking outer drainage tube, and relates to the technical field of medical instruments, the self-breaking outer drainage tube comprises a tube body, and the tube body comprises a drainage part, a breaking part, a leading-out part and a puncture part; the drainage part and the fracture part are both made of degradable materials; the hole wall thickness of the circulation hole at the fracture part is smaller than the hole wall thickness of the circulation hole at the drainage part; during surgical operation, the degradable inner drainage part is placed in the pancreatic duct, the fracture part crosses the anastomotic stoma by 7-8 cm and crosses the biliary-intestinal anastomotic stoma, and the leading-out part walks in the enteric cavity to a proper position, penetrates out of the intestinal wall and is led out of the body through the abdominal wall. Cutting the puncture part to expose the outlet of the circulation hole, and discharging the body fluid through the circulation hole; after a certain period of time after the operation, the fracture part is automatically fractured under the action of pancreatic juice, the leading-out part is pulled out, the degradable drainage part continues to be degraded in the body and maintains the drainage function, and finally the drainage part is absorbed by the body or discharged out of the body without being taken out through the operation.
Owner:WUXI ZHONGKE GUANGYUAN BIOMATERIALS

Method for surgical removal of pathological contents of maxillary sinuses before sinus lifting

ActiveRU2865398C1Endotracheal anaesthesiaNasal passages
FIELD: otorhinolaryngology.SUBSTANCE: under endotracheal anesthesia, an endoscope equipped with optics and an instrument for removing pathological contents of the maxillary sinus are inserted into the nasal passage. The inferior nasal concha is displaced medially using a raspatory. Then, stepping back from the edge of the piriform opening by 1.5–2.0 cm in the caudal direction, a mucoperiosteal flap of the lateral wall is separated in the lower nasal passage. The mucoperiosteal flap is displaced posteriorly, exposing the bone skeleton in the projection of the inferomedial angle of the maxillary sinus. Next, using a cold plasma coblator, in ablation mode, the mucous surface of the bone skeleton is evaporated for 2–3 seconds, followed by coagulation of small vessels. Then, a bone valve measuring 10–15 mm is formed from the exposed bone skeleton. The bony valve is retracted in the caudal direction, forming an antrostomy. A 70-degree endoscope is inserted through the formed antrostomy and the pathological contents of the sinus are visualized. In this case, if the cyst is visualized with a coblator in ablation mode, the cyst is evaporated along with its contents, and the remaining cyst is captured and removed. If a polyp is visualized, the polyp stalk is first evaporated, and then the remaining part of the polyp is removed. If a foreign body is visualized, it is removed with forceps. In this case, if the foreign body is encapsulated or located in the thickness of the mucosa, a coblator in ablation mode evaporates part of the mucosa until the foreign body is exposed, and then removed. Next, the sinus cavity is washed with saline solution. The antrostomy is closed with a bone flap. The formed mucoperiosteal flap is placed back in its original place.EFFECT: method allows for endoscopic endonasal removal of pathological contents from the maxillary sinuses with a minimal risk of cyst / polyp recurrence and postoperative complications, reduced blood loss during surgery, shortened surgical time, postoperative rehabilitation periods, and temporary disability.3 cl, 3 ex
Owner:СТАНИШЕВСКИЙ РУСЛАН ОЛЕГОВИЧ

Minimally invasive surgery taking-out device and taking-out system

The utility model discloses a minimally invasive surgery taking-out device and a taking-out system. The taking-out device can comprise a passage piece, a fixing clamp and a cutter. Wherein the access piece is used for establishing a surgical access for surgical operation; the fixing clamp and the cutter can be used for extending into the surgical access and extending out of the far end of the access piece; the fixing clamp is used for fixing and clamping the cut target extraction object, and the cutter is used for cutting the target extraction object and taking out the cut target extraction object through the fixing clamp. On one hand, compared with a plurality of operation channels, the taking-out device has the advantages that the operation risk is reduced through one operation channel; on the other hand, the object is fixedly clamped and taken out through the fixing clamp, so that the object to be taken out is firmly clamped, the risk that a filter screen is not used for filtering thoroughly is also avoided, and the operation safety is enhanced; and thirdly, the fixing clamp and the cutter are matched for operation, so that the operation precision is improved.
Owner:BEIJING BALANCE MEDICAL

Fluorescence imaging agent for lung cancer resection

PCT designated stageWO2026117671A1Powder deliveryInorganic non-active ingredientsSurgical removalImaging agent
Provided herein are methods for the surgical removal of lung cancer tissue using CXL, a near-infrared fluorescent imaging agent. This approach involves administering a pharmaceutical composition containing CXL intravenously to a patient, detecting a fluorescence signal emitted from lung cancer tissues, and surgically excising the identified cancerous tissue. Administration doses may range from about 0.001 mg / kg to about 0.10 mg / kg, occurring between up to 4 days and about 1 hour before imaging. The method supports endoscopic imaging and surgeries, including thoracoscopic lung tissue resection, intraoperative visualization, and histopathological evaluation to confirm tissue removal. Exclusion criteria cover hypersensitivity history, renal impairment, and specific laboratory markers exceeding defined limits.
Owner:INTEGRO THERANOSTICS LLC

A powder composition for preventing and treating symblepharon, and a preparation method and use thereof

PendingCN122272507ASurgical removalPharmaceutical drug
This invention discloses a powder composition for the prevention and treatment of symblepharon (eyelid-eye-ball adhesion). The powder composition comprises a polymer material that cross-links with each other upon contact with an aqueous medium, forming a hydrogel isolation membrane in situ at the wound surface. This invention also discloses the application of the above-mentioned powder composition in the preparation of medicaments for the prevention and / or treatment of symblepharon. The powder composition provided by this invention, when applied to ocular surface wounds, rapidly forms a physical isolation layer in situ. This formed physical isolation layer exhibits good stability and can be gradually and gently degraded without the need for secondary surgical removal.
Owner:SECOND AFFILIATED HOSPITAL ZHEJIANG UNIV COLLEGE OF MEDICINE

Striking apparatus for a medical extracting tool

PendingUS20260108287A1ProsthesisOsteosynthesis devicesSurgical removalApparatus instruments
A striking apparatus and method is described for enhancing the surgical removal of medical devices, such as surgical screws and the like. The striking apparatus may include an elongated body that may include an annular distal end, a neck extending from the elongated body; and a fastener extending from the neck. The elongated body may include a first tapering portion extending from the annular distal end and a second tapering portion extending from the first tapering portion. The first tapering portion may be an annular first tapering portion. The striking apparatus may detachably couple with a medical extractor, thus providing additional force to the extracting mechanism provided by the extracting tool.
Owner:SHUKLA MEDICAL INC

Augmented-reality endoscopic vessel harvesting

ActiveUS12564471B2Image enhancementImage analysisSurgical removalEndoscopic vessel harvesting
An endoscopic vessel harvesting system for surgical removal of a blood vessel to be used for coronary bypass uses endoscopic instruments for isolating and severing the vessel. An endoscopic camera in the endoscopic instruments captures images from a distal tip of the instrument within a dissected tunnel around the vessel. An image processor assembles a three-dimensional model of the tunnel from a series of images captured by the endoscopic camera. An augmented-reality display coupled to the image processor renders (e.g., visibly displays to the user in their field of view) a consolidated map representing the three-dimensional model along with a marker in association with the map indicating a current location of the distal tip.
Owner:TERUMO CARDIOVASCULAR SYSTEMS CORP

A system for evaluating the effectiveness of honey and hydrogel in the treatment of diabetic foot ulcers

UndeterminedDE202026103638U1Surgical removalEfficacy
A system for evaluating the efficacy of honey and hydrogel in the treatment of diabetic foot ulcers in patients with type 2 diabetes mellitus, comprising: a) a wound preparation unit configured for the surgical removal of necrotic tissue and calluses in diabetic foot ulcers; b) a topical treatment unit configured to apply at least one therapeutic agent selected from the group consisting of honey gel, hydrogel, a combination of honey gel and hydrogel, or topical antibiotic ointment to the wound bed; c) a relief unit configured to provide pressure relief devices for the ulcer site; and d) a monitoring unit configured to measure wound size and track healing progress at predetermined intervals.
Owner:ABDALQADER MOHAMMED +6

Striking apparatus for a medical extracting tool

PCT designated stageWO2026090261A1ProsthesisOsteosynthesis devicesSurgical removalApparatus instruments
A striking apparatus and method is described for enhancing the surgical removal of medical devices, such as surgical screws and the like. The striking apparatus may include an elongated body that may include an annular distal end, a neck extending from the elongated body; and a fastener extending from the neck. The elongated body may include a first tapering portion extending from the annular distal end and a second tapering portion extending from the first tapering portion. The first tapering portion may be an annular first tapering portion. The striking apparatus may detachably couple with a medical extractor, thus providing additional force to the extracting mechanism provided by the extracting tool.
Owner:SHUKLA MEDICAL INC

Synthetic thrombus model for learning the surgical removal of a blood clot in the context of a treatment simulation

Synthetic thrombus model for learning the surgical removal of a blood clot from a blood vessel using mechanical thrombectomy in a simulation of various stroke scenarios in a training model, which simulates a lifelike shape with a realistic feel of a human blood clot thereby that an elongated base body based on an elastically deformable main material with a Shore A hardness in the range of 0 to 10 is provided, the property profile of which at least with respect to hardness and fragmentation is improved by providing a material combination of the main material with at least one addition of an adhesive with 5 to 40 wt.-% and / or with a reinforcing material.
Owner:TECHN UNIV HAMBURG HARBURG

A visual retractor system for lower blepharoplasty surgery

ActiveCN224461739USurgical operationOrbital septum
This utility model relates to a visual retractor system specifically designed for surgical removal of orbital septum fat in eye bags, belonging to the field of medical device technology. It includes a main retractor and a pair of auxiliary retractors. One end of the main retractor has a main hook body, and one end of each of the pair of auxiliary retractors has an auxiliary hook body. The pair of auxiliary retractors are mounted on the main retractor, with the auxiliary hook bodies at one end distributed on both sides of the main hook body. The pair of auxiliary retractors can be moved relative to each other, either so that the auxiliary hook bodies are close to the main hook body from both sides, or so that they are far away from the main hook body from both sides. A camera system is installed on the main retractor near the main hook body. Advantages: The structure is rationally designed, allowing the main hook body to pull open the lower eyelid while the pair of auxiliary hook bodies simultaneously pull apart the orbital septum fat and tissue, exposing the internal space of the orbital septum to the field of view of the camera system, thus facilitating the surgeon's removal of the orbital septum fat and tissue.
Owner:PLASTIC SURGERY HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCES